Ivermectin is indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract Ivermectin is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis.
From the U.S. FDA-approved label for Ivermectin. Full label: DailyMed.
Ivermectin is indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract Ivermectin is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin (See CLINICAL PHARMACOLOGY, Clinical Studies ). Onchocerciasis Ivermectin is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C). NOTE: Ivermectin has no activity against adult Onchocerca volvulus parasites.
From the U.S. FDA-approved label for Ivermectin. Full label: DailyMed.
Strongyloidiasis The recommended dosage of ivermectin Tablets for the treatment of strongyloidiasis is a single oral dose designed to provide approximately 200 mcg of ivermectin per kg of body weight. See Table 1 for dosage guidelines. Patients should take tablets on an empty stomach with water (See CLINICAL PHARMACOLOGY, Pharmacokinetics ).
Directions from the U.S. FDA-approved label for Ivermectin — your doctor or pharmacist may advise differently.
Ivermectin Tablets are contraindicated in patients who are hypersensitive to any component of this product.
Excerpt from the U.S. FDA-approved label for Ivermectin. Talk to a pharmacist or doctor before use.
Historical data have shown that microfilaricidal drugs, such as diethylcarbamazine citrate (DEC-C), might cause cutaneous and/or systemic reactions of varying severity (the Mazzotti reaction) and ophthalmological reactions in patients with onchocerciasis. These reactions are probably due to allergic and inflammatory responses to the death of microfilariae. Patients treated with ivermectin for onchocerciasis may experience these reactions in addition to clinical adverse reactions possibly, probably, or definitely related to the drug itself (See ADVERSE REACTIONS, Onchocerciasis ).
Warnings and precautions excerpt from the U.S. FDA-approved label for Ivermectin — not a complete list. Talk to a pharmacist or doctor before use.
Strongyloidiasis In four clinical studies involving a total of 109 patients given either one or two doses of 170 to 200 mcg/kg of ivermectin, the following adverse reactions were reported as possibly, probably, or definitely related to ivermectin: Body as a Whole: asthenia/fatigue (0.9%), abdominal pain (0.9%) Gastrointestinal: anorexia (0.9%), constipation (0.9%), diarrhea (1.8%), nausea (1.8%), vomiting (0.9%) Nervous…
Excerpt from the U.S. FDA-approved label for Ivermectin — not a complete list. Talk to a pharmacist or doctor about side effects.
5 brands · 3 makers in the NepalDoc catalog — see the full Ivermectin guide →
Store at temperatures below 30°C (86°F).
Storage information from the U.S. FDA-approved label for Ivermectin.
What is Iver DT?
Iver DT 12mg Tablet is a Ivermectin medicine made by Alive Pharmaceutical. Pvt. Ltd. It comes as 12mg Tablet.
What is the generic name of Iver DT?
The generic name of Iver DT is Ivermectin.
Which brands of Ivermectin are available in Nepal?
5 brands of Ivermectin are listed in the NepalDoc catalog, from 3 makers — including Gmectin 6mg Tablet, Iver DT 6mg Tablet, Iver DT 3mg Tablet, Ivermed 6mg Tablet.
What are the side effects of Ivermectin?
Strongyloidiasis In four clinical studies involving a total of 109 patients given either one or two doses of 170 to 200 mcg/kg of ivermectin, the following adverse reactions were reported as possibly, probably, or definitely related to ivermectin: Body as a Whole: asthenia/fatigue (0.9%), abdominal pain (0.9%) Gastrointestinal: anorexia (0.9%), constipation (0.9%), diarrhea (1.8%), nausea (1.8%), vomiting (0.9%) Nervous…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
